Compare DLX & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DLX | CBLL |
|---|---|---|
| Founded | 1915 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 935.3M |
| IPO Year | 1994 | 2024 |
| Metric | DLX | CBLL |
|---|---|---|
| Price | $23.48 | $27.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $32.25 | $28.57 |
| AVG Volume (30 Days) | ★ 384.1K | 380.0K |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | ★ 5.03% | N/A |
| EPS Growth | 52.54 | ★ 56.93 |
| EPS | ★ 1.18 | N/A |
| Revenue | ★ $2,133,200,000.00 | $89,063,000.00 |
| Revenue This Year | N/A | $29.66 |
| Revenue Next Year | $5.06 | $27.36 |
| P/E Ratio | $20.28 | ★ N/A |
| Revenue Growth | 0.54 | ★ 36.09 |
| 52 Week Low | $17.76 | $10.85 |
| 52 Week High | $32.07 | $28.11 |
| Indicator | DLX | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 52.27 | 60.73 |
| Support Level | $23.30 | $22.64 |
| Resistance Level | $24.60 | N/A |
| Average True Range (ATR) | 0.57 | 1.52 |
| MACD | 0.11 | 0.22 |
| Stochastic Oscillator | 71.64 | 86.16 |
Deluxe Corp is principally a payments and data company. Its reportable segments are: Merchant Services, B2B Payments, Data Solutions, and Print. Maximum revenue is derived from its Print segment, which provides printed personal and business checks, business essentials, as well as branded promotional, print, apparel, and digital storefront solutions. The Merchant Services segment provides electronic credit and debit card authorization, payment systems, and processing services. The B2B segment offers treasury management solutions, integrated accounts payable disbursements, and fraud and security services, and the Data Solutions segment offers data, analytics, and marketing services, as well as financial institution profitability reporting and business incorporation services.
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.